ArticleFrontiers in oncology2021

Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.

Yujia Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.